Changing TH1/TH2 balance in split influenza vaccines with adjuvants

Details for Australian Patent Application No. 2006310340 (hide)

Owner Novartis Vaccines and Diagnostics SRL

Inventors O'Hagan, Derek

Agent FB Rice

Pub. Number AU-B-2006310340

PCT Pub. Number WO2007/052059

Priority 60/734,026 04.11.05 US; 60/812,475 08.06.06 US

Filing date 6 November 2006

Wipo publication date 10 May 2007

Acceptance publication date 10 February 2011

International Classifications

A61K 39/145 (2006.01) Medicinal preparations containing antigens or antibodies - Orthomyxoviridae, e.g. influenza virus

A61K 39/39 (2006.01) Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

Event Publications

5 June 2008 PCT application entered the National Phase

  PCT publication WO2007/052059 Priority application(s): WO2007/052059

10 February 2011 Application Accepted

  Published as AU-B-2006310340

9 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006310341-Influenza vaccines extemporaneously adsorbed to aluminium adjuvants

2006310339-Influenza vaccines including combinations of particulate adjuvants and immunopotentiators